Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease

Cited by papers we hold 5

• Inflammation context in Alzheimer’s disease, a relationship intricate to define · 2022
  No notice
• Oxidative toxicity in diabetes and Alzheimer’s disease: mechanisms behind ROS/ RNS generation · 2017
  No notice
• Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies · 2016
  No notice
• Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer’s Disease · 2015
  No notice
• Mitochondrial oxidative stress in aging and healthspan · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.